According to the modern research definition by the National Institute on Aging and the Alzheimer’s Association [10], Alzheimer’s disease is a designation for individuals who exhibit pathological amyloid-β and tau deposits, determined either through positron emission tomography or cerebrospinal fluid evaluation. Here, MAPT is linked to Alzheimer disease.